Literature DB >> 30332668

Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer.

Caizhao Lin1, Xiaolu Cai2, Jing Zhang2, Weibing Wang1, Qinsong Sheng1, Hanju Hua1, Xile Zhou3.   

Abstract

Human guts harbor abundant microbes that regulate many aspects of host physiology. However, bacterial imbalance or dysbiosis in the gut due to the dietary or environmental changes may cause colorectal cancer (CRC). Increasing studies show that gut microbiota plays an important role in the occurrence and development of CRC, as a result of virulence factors, bacterial metabolites, or inflammatory pathways. In the future, probiotics or targeting the microbiota will probably be a powerful weapon in the battle against CRC. This review seeks to outline the relationship between gut microbiota and the development of CRC as well as the potential mechanisms of microbiota involved in treatment of CRC, so as to provide some references for research on the development, prevention, and treatment of this disease.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Chemotherapy; Colorectal cancer; Gut microbiota; Immunotherapy; Probiotics

Mesh:

Substances:

Year:  2018        PMID: 30332668     DOI: 10.1159/000494052

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  24 in total

Review 1.  The role of gut microbiota in the development of colorectal cancer: a review.

Authors:  Navami Koyande; Madhusree Gangopadhyay; Shashidhar Thatikonda; Aravind Kumar Rengan
Journal:  Int J Colorectal Dis       Date:  2022-06-15       Impact factor: 2.796

Review 2.  Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora.

Authors:  Hourieh Sadrekarimi; Zhanna R Gardanova; Morteza Bakhshesh; Farnoosh Ebrahimzadeh; Amirhossein Fakhre Yaseri; Lakshmi Thangavelu; Zahra Hasanpoor; Firoozeh Abolhasani Zadeh; Mohammad Saeed Kahrizi
Journal:  J Transl Med       Date:  2022-07-06       Impact factor: 8.440

Review 3.  Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy.

Authors:  Ming Yi; Dechao Jiao; Shuang Qin; Qian Chu; Anping Li; Kongming Wu
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

Review 4.  Integrating the Tumor Microenvironment into Cancer Therapy.

Authors:  Sabina Sanegre; Federico Lucantoni; Rebeca Burgos-Panadero; Luis de La Cruz-Merino; Rosa Noguera; Tomás Álvaro Naranjo
Journal:  Cancers (Basel)       Date:  2020-06-24       Impact factor: 6.639

Review 5.  HIV, Cancer, and the Microbiota: Common Pathways Influencing Different Diseases.

Authors:  Sabina Herrera; Javier Martínez-Sanz; Sergio Serrano-Villar
Journal:  Front Immunol       Date:  2019-06-27       Impact factor: 7.561

6.  The Influence of Caerulomycin A on the Intestinal Microbiota in SD Rats.

Authors:  Hongwei Zhang; Mengmeng Lan; Guodong Cui; Weiming Zhu
Journal:  Mar Drugs       Date:  2020-05-22       Impact factor: 5.118

Review 7.  Fungal Gut Microbiota Dysbiosis and Its Role in Colorectal, Oral, and Pancreatic Carcinogenesis.

Authors:  Karolina Kaźmierczak-Siedlecka; Aleš Dvořák; Marcin Folwarski; Agnieszka Daca; Katarzyna Przewłócka; Wojciech Makarewicz
Journal:  Cancers (Basel)       Date:  2020-05-22       Impact factor: 6.639

8.  In Vitro Fecal Fermentation Patterns of Arabinoxylan from Rice Bran on Fecal Microbiota from Normal-Weight and Overweight/Obese Subjects.

Authors:  Inah Gu; Wing Shun Lam; Daya Marasini; Cindi Brownmiller; Brett J Savary; Jung Ae Lee; Franck Carbonero; Sun-Ok Lee
Journal:  Nutrients       Date:  2021-06-15       Impact factor: 5.717

9.  Circulating Exosomal miR-150-5p and miR-99b-5p as Diagnostic Biomarkers for Colorectal Cancer.

Authors:  Ya Jing Zhao; Xingguo Song; Limin Niu; Youyong Tang; Xianrang Song; Li Xie
Journal:  Front Oncol       Date:  2019-10-23       Impact factor: 6.244

Review 10.  Immune Dysfunctions and Immunotherapy in Colorectal Cancer: The Role of Dendritic Cells.

Authors:  Sandra Gessani; Filippo Belardelli
Journal:  Cancers (Basel)       Date:  2019-10-03       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.